164 related articles for article (PubMed ID: 22801592)
1. Cholecystokinin and gastrin receptors targeting in gastrointestinal cancer.
Rai R; Chandra V; Tewari M; Kumar M; Shukla HS
Surg Oncol; 2012 Dec; 21(4):281-92. PubMed ID: 22801592
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
Béhé M; Behr TM
Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
[TBL] [Abstract][Full Text] [Related]
3. Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors.
Reubi JC; Schaer JC; Waser B
Cancer Res; 1997 Apr; 57(7):1377-86. PubMed ID: 9102227
[TBL] [Abstract][Full Text] [Related]
4. Biology of gut cholecystokinin and gastrin receptors.
Shulkes A; Baldwin GS
Clin Exp Pharmacol Physiol; 1997; 24(3-4):209-16. PubMed ID: 9131287
[TBL] [Abstract][Full Text] [Related]
5. Insights into the binding and activation sites of the receptors for cholecystokinin and gastrin.
Foucaud M; Archer-Lahlou E; Marco E; Tikhonova IG; Maigret B; Escrieut C; Langer I; Fourmy D
Regul Pept; 2008 Jan; 145(1-3):17-23. PubMed ID: 17961734
[TBL] [Abstract][Full Text] [Related]
6. Gastrin increases its own synthesis in gastrointestinal cancer cells via the CCK2 receptor.
Kovac S; Xiao L; Shulkes A; Patel O; Baldwin GS
FEBS Lett; 2010 Nov; 584(21):4413-8. PubMed ID: 20932834
[TBL] [Abstract][Full Text] [Related]
7. The Role of Gastrin and CCK Receptors in Pancreatic Cancer and other Malignancies.
Smith JP; Fonkoua LK; Moody TW
Int J Biol Sci; 2016; 12(3):283-91. PubMed ID: 26929735
[TBL] [Abstract][Full Text] [Related]
8. Gastrins, cholecystokinins and gastrointestinal cancer.
Aly A; Shulkes A; Baldwin GS
Biochim Biophys Acta; 2004 Jul; 1704(1):1-10. PubMed ID: 15238241
[TBL] [Abstract][Full Text] [Related]
9. Coexpression of gastrin and gastrin receptors (CCK-B and delta CCK-B) in gastrointestinal tumour cell lines.
McWilliams DF; Watson SA; Crosbee DM; Michaeli D; Seth R
Gut; 1998 Jun; 42(6):795-8. PubMed ID: 9691917
[TBL] [Abstract][Full Text] [Related]
10. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.
Behr TM; Béhé M; Angerstein C; Gratz S; Mach R; Hagemann L; Jenner N; Stiehler M; Frank-Raue K; Raue F; Becker W
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3124s-3138s. PubMed ID: 10541353
[TBL] [Abstract][Full Text] [Related]
11. CCK-A- and CCK-B-like receptors in the gallbladder and stomach of the alligator (Alligator mississippiensis).
Oliver AS; Vigna SR
Gen Comp Endocrinol; 1997 Jan; 105(1):91-101. PubMed ID: 9000471
[TBL] [Abstract][Full Text] [Related]
12. Targeting gastrin for the treatment of gastric acid related disorders and pancreatic cancer.
Morton M; Prendergast C; Barrett TD
Trends Pharmacol Sci; 2011 Apr; 32(4):201-5. PubMed ID: 21397342
[TBL] [Abstract][Full Text] [Related]
13. Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization.
Zhou W; Povoski SP; Longnecker DS; Bell RH
Cancer Res; 1992 Dec; 52(24):6905-11. PubMed ID: 1458479
[TBL] [Abstract][Full Text] [Related]
14. The role of gastrin and cholecystokinin in normal and neoplastic gastrointestinal growth.
Baldwin GS
J Gastroenterol Hepatol; 1995; 10(2):215-32. PubMed ID: 7787172
[TBL] [Abstract][Full Text] [Related]
15. Cholecystokinin, gastrin, cholecystokinin/gastrin receptors, and bitter taste receptor TAS2R14: trophoblast expression and signaling.
Taher S; Borja Y; Cabanela L; Costers VJ; Carson-Marino M; Bailes JC; Dhar B; Beckworth MT; Rabaglino MB; Post Uiterweer ED; Conrad KP
Am J Physiol Regul Integr Comp Physiol; 2019 May; 316(5):R628-R639. PubMed ID: 30892908
[TBL] [Abstract][Full Text] [Related]
16. Responses of human sling and clasp fibers to cholecystokinin (CCK) and gastrin through CCK receptors.
Liu JF; Gao LP; Wen SW; Lu HL; Zhang J; Sun J; Zhang SW; Wang QZ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1608-12. PubMed ID: 18444993
[TBL] [Abstract][Full Text] [Related]
17. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
[TBL] [Abstract][Full Text] [Related]
18. Pre-clinical evaluation of a new orally-active CCK-2R antagonist, Z-360, in gastrointestinal cancer models.
Grabowska AM; Morris TM; McKenzie AJ; Kumari R; Hamano H; Emori Y; Yoshinaga K; Watson SA
Regul Pept; 2008 Feb; 146(1-3):46-57. PubMed ID: 17961733
[TBL] [Abstract][Full Text] [Related]
19. Progress in developing cholecystokinin (CCK)/gastrin receptor ligands that have therapeutic potential.
Berna MJ; Tapia JA; Sancho V; Jensen RT
Curr Opin Pharmacol; 2007 Dec; 7(6):583-92. PubMed ID: 17997137
[TBL] [Abstract][Full Text] [Related]
20. The effects of antagonists of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
Dembiński A; Warzecha Z; Konturek SJ; Cai RZ; Schally AV
J Physiol Pharmacol; 1991 Jun; 42(2):195-209. PubMed ID: 1664265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
